PathGroup’s new Vaginal Health Portfolio utilizes the most advanced PCR technology, providing accurate and actionable answers in less time for the most common infections of the genital tract. And with a dedicated panel for Bacterial Vaginosis, you’ll gain valuable insights into your patient’s vaginal ecosystem for more targeted and effective management.
PathGroup’s Vaginal Health Portfolio is comprised of tailored, infection-specific panels providing clinically relevant and actionable results for:
- Bacterial Vaginosis+
- Candida
- Leukorrhea
- Vaginitis
- Aerobic Vaginitis
- STI/STD
- Genital Ulcer
Early & Accurate Detection
- Industry leading turnaround times
- 31 organisms providing superior sensitivity and specificity
- Clinically relevant, infection-specific panels
- Single sample, convenient collection
In-Network Strategy
- All insurances accepted – preferred provider status with an extensive payer list
- Over 98% of claims are processed in-network annually
- Meaningful, cost-conscience test utilization
Innovative Technology, Actionable Results
- Tailored, clinically relevant panels focused on key infectious organisms
- Advanced PCR technology for quantitative results
- Straightforward reports with simple informatics and clinically actionable data
- HL7-compliant reports for ease of use and interpretation
To partner with PathGroup, call 800.366.5847 or email marketing@pathgroup.com for more information.